Design, synthesis, and biological evaluation of novel (1-thioxo-1,2,3,4-tetrahydro-β-carbolin-9-yl)acetic acids as selective inhibitors for AKR1B1
Daisuke Minehira(Toyama University Hospital), Naoki Toyooka(University of Toyama), Satoshi Endo, Mayuko Takemura(Gifu Pharmaceutical University), Kayo Narukawa(Kitasato University), Jun Koseki(Kitasato University), Hirokazu Urata(Toyama University Hospital), Kenji Sugimoto(University of Toyama), Daisuke Takeda(Toyama University Hospital), Atsushi Kato(University of Toyama), Isao Adachi(Toyama University Hospital), Xu Wang(Western University), Toshiyuki Matsunaga(Gifu Pharmaceutical University), Yûji Matsuya(University of Toyama), Shuichi Hirono(Kitasato University), Akira Hara(Gifu University)
Cited by 11
Related Papers
TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway
|Journal of Experimental & Clinical Cancer Research|2018|156
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation
|Cancer Cell|2018|155
Pleiotrophin: Activity and mechanism
|Advances in clinical chemistry|2020|112
Molecular Characterization of Mammalian Dicarbonyl/l-Xylulose Reductase and Its Localization in Kidney
|Journal of Biological Chemistry|2002|101